Takeda to Sell Non-Colcrys URL Pharma, Inc. Generic Business to Sun Pharmaceutical


Deerfield, Ill., Dec. 17, 2012 and Osaka, Japan, Dec. 18, 2012 – Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda’s wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) has entered into a definitive agreement with Caraco Pharmaceutical Laboratories, Ltd. (Caraco), a wholly-owned subsidiary of Sun Pharmaceutical Industries, Ltd. for the sale of the non-Colcrys (colchicine, USP) URL Pharma, Inc.* generic business.

 Read more


Top of page

Takeda Pharma